- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Abbvie Inc DRC (ABBV)
Track today's live Abbvie DRC (ABBV) share price, performance and key data on this page with our current CBOE Canada:ABBV stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Abbvie DRC share price on the CBOE Canada exchange. Use the dropdown to switch exchange for the ABBV share price, head to our technical summary section, which provides analysis on Abbvie DRC share price buy/sell indicators using real-time data (or discuss the Abbvie DRC (ABBV) stock price today with other investors in the Abbvie DRC NLB share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NLB:ABBV share price (ISIN: CA00288K1084) to enhance your trading decisions with our free investment tools and resources.
What Is the Abbvie Inc DRC Share Price Today?
The Abbvie DRC share price today is 33.83.
What Is the Stock Symbol for Abbvie Inc DRC
The stock symbol (or 'ticker') for Abbvie Inc DRC is "ABBV."
What Stock Exchange Does Abbvie Inc DRC Trade On?
Abbvie Inc DRC is listed and trades on the CBOE Canada stock exchange.
Is Abbvie Inc DRC a Good Stock to Buy?
Determining whether Abbvie DRC (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NLB:ABBV share price (ISIN: CA00288K1084) to enhance your trading decisions with our free investment tools and resources.
What Is the Abbvie Inc DRC Share Price Today?
The Abbvie DRC share price today is 33.83.
What Is the Stock Symbol for Abbvie Inc DRC
The stock symbol (or 'ticker') for Abbvie Inc DRC is "ABBV."
What Stock Exchange Does Abbvie Inc DRC Trade On?
Abbvie Inc DRC is listed and trades on the CBOE Canada stock exchange.
Is Abbvie Inc DRC a Good Stock to Buy?
Determining whether Abbvie DRC (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
33.83
-1.37(-3.89%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
33.83
33.98
52 wk Range
27.73
37.14
ABBV is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
33.8333.98
52 wk Range
27.7337.14
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.84%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.84%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ABBV Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Earnings
Latest Release
31/07/2026
EPS / Forecast
2.03 / --
Revenue / Forecast
16.99B / --
Compare ABBV to Peers and Sector
Metrics to compare | ABBV | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipABBVPeersSector | |
|---|---|---|---|---|
P/E Ratio | 68.7x | 22.1x | −0.4x | |
PEG Ratio | 1.00 | −0.36 | 0.00 | |
Price/Book | −72.6x | 1.2x | 2.6x | |
Price / LTM Sales | 6.7x | 2.6x | 3.0x | |
Upside (Analyst Target) | - | 26.4% | 50.7% | |
Fair Value Upside | Unlock | 7.8% | 7.2% | Unlock |
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox Cosmetic for the treatment of glabellar lines, crow's feet, forehead lines, and platysma bands; Juvederm Collection to treat volume loss in the temples, undereye, cheeks, chin, lips and lower face; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; Qulipta for episodic and chronic migraine; and Vyalev for the treatment of motor fluctuations, as well as Botox Therapeutic to treat chronic migraine, overactive bladder, spasticity, cervical dystonia, and other conditions. In addition, the company offers Ozurdex for visual impairment; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; and other eye care products, including Refresh/Optive, Xen, Durysta, and Restasis. Further, it provides Mavyret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Abbvie DRC (CBOE Canada: ABBV) Share Price Today?
The Abbvie DRC stock price today is 33.83 CAD.
What Stock Exchange Does Abbvie DRC (ABBV) Trade On?
Abbvie DRC is listed and trades on the CBOE Canada Exchange.
What Is the Ticker (Stock Symbol) for Abbvie DRC?
The stock symbol (also called a 'ticker') for Abbvie DRC is "ABBV."
Does Abbvie DRC Pay Dividends? What’s The Current ABBV Dividend Yield?
Yes, ABBV Pays Dividends to its Shareholders. The current Abbvie DRC dividend yield is 2.84%.
What Is the Current Abbvie DRC Market Capitalisation?
As of today, Abbvie DRC (CBOE Canada: ABBV) market cap is 603.89B CAD.
What Is Abbvie DRC's (ABBV) Earnings Per Share (TTM)?
The Abbvie DRC EPS is currently 3.54 (Trailing Twelve Months).
Is ABBV a Buy or Sell From a Technical Analyst Perspective?
Based on today's Abbvie DRC moving averages and other technical indicators, the daily buy/sell signal for ABBV stock is Sell.
How Many Times Has Abbvie DRC Stock Split?
Abbvie DRC has split 0 times. (See the ABBV stock split history page for full effective split date and price information.)
How Many Employees Does Abbvie DRC Have?
Abbvie DRC has 57000 employees, based on their latest Companies House report.
What is the current trading status of Abbvie DRC (CBOE Canada: ABBV)?
As of 07/08/2026, Abbvie DRC (ABBV) is trading at a share price of 33.83 CAD, with a previous close of 33.83 CAD. The stock has fluctuated within a day range of 33.83 CAD to 33.98 CAD, while its 52-week range spans from 27.73 CAD to 37.14 CAD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.